The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback